Vaccine targets cancer-causing virus.
A vaccine that protects against cervical cancer has shown to be well tolerated in early tests in people. Further testing is needed to determine if the vaccine can protect women from cervical cancer. In the meantime, a test is available that can tell physicians which women with inconclusive Pap results need further testing. Vaccine targets caner-cusing virus. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine.